Tech Company Financing Transactions
Ordaos Funding Round
Ordaos, operating out of New York, raised $5 million in investment from Middleland Capital, Citta Capital and IAG Capital Partners.
Transaction Overview
Company Name
Announced On
8/26/2022
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
228 Park Ave. S 60684
New York, NY 10003
USA
New York, NY 10003
USA
Phone
Undisclosed
Website
Email Address
Overview
For each client, we create billions of proteins and evaluate their properties in silico to reliably and repeatedly deliver the de novo mini-proteins that drug hunters only dream of. We then prove our consistency and unparalleled efficacy by rigorously synthesizing and testing top-ranking sequences in vitro.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Longo
VP - Bus. Development
Georgina Colquhoun
VP - Engineering
Matthias Denecke
VP - Operations
Jacob Tourjeman
VP - Product Management
Tim Shelburne
VP - R & D
Ziwei Liang
Browse more venture capital transactions:
Prev: 8/26/2022: Avium venture capital transaction
Next: 8/26/2022: promiseQ venture capital transaction
Share this article
About Database of VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs